JP Morgan Chase’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.8K | Buy |
4,463
+4,267
| +2,177% | +$23.8K | ﹤0.01% | 6525 |
|
|
2025
Q4 | $1.31K | Buy |
196
+32
| +20% | +$190 | ﹤0.01% | 6999 |
|
|
2025
Q3 | $718 | Buy |
+164
| New | +$778 | ﹤0.01% | 7022 |
|
|
2025
Q2 | – | Sell |
-4,094
| Closed | -$23.2K | – | 7321 |
|
|
2025
Q1 | $23.2K | Sell |
4,094
-7,265
| -64% | -$93K | ﹤0.01% | 6109 |
|
|
2024
Q4 | $240K | Buy |
11,359
+8,409
| +285% | +$193K | ﹤0.01% | 5399 |
|
|
2024
Q3 | $79.4K | Buy |
2,950
+1,140
| +63% | +$33.6K | ﹤0.01% | 5794 |
|
|
2024
Q2 | $51.6K | Buy |
1,810
+139
| +8% | +$4.88K | ﹤0.01% | 5849 |
|
|
2024
Q1 | $70.9K | Sell |
1,671
-1,060
| -39% | -$47.7K | ﹤0.01% | 5806 |
|
|
2023
Q4 | $146K | Hold |
2,731
| – | – | ﹤0.01% | 5557 |
|
|
2023
Q3 | $117K | Sell |
2,731
-388
| -12% | -$17.9K | ﹤0.01% | 5383 |
|
|
2023
Q2 | $171K | Buy |
3,119
+3,033
| +3,527% | +$166K | ﹤0.01% | 5168 |
|
|
2023
Q1 | $4K | Hold |
86
| – | – | ﹤0.01% | 6284 |
|
|
2022
Q4 | $2K | Sell |
86
-169
| -66% | -$4.17K | ﹤0.01% | 6311 |
|
|
2022
Q3 | $7K | Buy |
255
+92
| +56% | +$3.04K | ﹤0.01% | 6025 |
|
|
2022
Q2 | $6K | Sell |
163
-2,151
| -93% | -$97.1K | ﹤0.01% | 6119 |
|
|
2022
Q1 | $143K | Sell |
2,314
-1,055
| -31% | -$62.4K | ﹤0.01% | 5353 |
|
|
2021
Q4 | $237K | Buy |
3,369
+1,522
| +82% | +$108K | ﹤0.01% | 5255 |
|
|
2021
Q3 | $129K | Sell |
1,847
-3,009
| -62% | -$239K | ﹤0.01% | 5441 |
|
|
2021
Q2 | $404K | Sell |
4,856
-7,013
| -59% | -$496K | ﹤0.01% | 4829 |
|
|
2021
Q1 | $648K | Buy |
11,869
+260
| +2% | +$12.6K | ﹤0.01% | 4521 |
|
|
2020
Q4 | $498K | Buy |
11,609
+7,737
| +200% | +$289K | ﹤0.01% | 4365 |
|
|
2020
Q3 | $117K | Sell |
3,872
-2,215
| -36% | -$74.5K | ﹤0.01% | 4614 |
|
|
2020
Q2 | $188K | Buy |
6,087
+2,499
| +70% | +$67.3K | ﹤0.01% | 4291 |
|
|
2020
Q1 | $79K | Buy |
3,588
+1,202
| +50% | +$32.6K | ﹤0.01% | 4590 |
|
|
2019
Q4 | $73K | Buy |
+2,386
| New | +$68.7K | ﹤0.01% | 5002 |
|
|
2019
Q2 | – | Sell |
-888
| Closed | -$38K | – | 5853 |
|
|
2019
Q1 | $38K | Sell |
888
-42
| -5% | -$1.52K | ﹤0.01% | 5222 |
|
|
2018
Q4 | $30K | Buy |
930
+103
| +12% | +$4.06K | ﹤0.01% | 5240 |
|
|
2018
Q3 | $43K | Sell |
827
-1,147
| -58% | -$64.4K | ﹤0.01% | 5255 |
|
|
2018
Q2 | $105K | Buy |
1,974
+1,435
| +266% | +$73.5K | ﹤0.01% | 4817 |
|
|
2018
Q1 | $27K | Buy |
+539
| New | +$24.2K | ﹤0.01% | 5000 |
|
|
2017
Q1 | – | Sell |
-612
| Closed | -$19K | – | 5122 |
|
|
2016
Q4 | $19K | Sell |
612
-1,308
| -68% | -$33.3K | ﹤0.01% | 4709 |
|
|
2016
Q3 | $52K | Buy |
1,920
+1,714
| +832% | +$47.6K | ﹤0.01% | 4025 |
|
|
2016
Q2 | $6K | Buy |
206
+165
| +402% | +$5.25K | ﹤0.01% | 4426 |
|
|
2016
Q1 | $1K | Hold |
41
| – | – | ﹤0.01% | 4566 |
|
|
2015
Q4 | $1K | Buy |
+41
| New | +$1.4K | ﹤0.01% | 4594 |
|
|
2014
Q2 | – | Sell |
-8,546
| Closed | -$405K | – | 3558 |
|
|
2014
Q1 | $405K | Buy |
+8,546
| New | +$389K | ﹤0.01% | 3197 |
|
|
2013
Q4 | – | Sell |
-2,755
| Closed | -$109K | – | 4151 |
|
|
2013
Q3 | $109K | Buy |
2,755
+466
| +20% | +$18.3K | ﹤0.01% | 4164 |
|
|
2013
Q2 | $81K | Buy |
+2,289
| New | +$87.6K | ﹤0.01% | 4195 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
